Crestline Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-7,100
Closed -$776K 168
2017
Q1
$776K Buy
+7,100
New +$776K 0.14% 67